Owlet Stock Before Q4 Earnings: Buy Now or Wait for Results?

Core Insights - Owlet, Inc. (OWLT) is set to report its fourth-quarter 2025 results on March 5, with previous earnings and revenues exceeding estimates by 113% and 20.5% respectively [2] - The company has shown consistent earnings surprises over the last three quarters, with an average surprise of 87.77% [3] - For Q4 2025, revenues are projected to grow by 24.1% year-over-year to $25.4 million, while the loss per share is estimated at 13 cents, reflecting an 85.7% decline from the previous year [6][8] Financial Performance - Owlet is expected to achieve a 34% revenue increase for 2025, with a projected 66.7% growth in its bottom line [4][6] - The Zacks Consensus Estimate for the current quarter indicates a loss per share of 13 cents, with a high estimate of -0.04 and a low estimate of -0.21 [5] Market Position and Growth Drivers - The company is transitioning from a hardware-focused model to a data-enabled pediatric health platform, benefiting from stronger brand positioning and subscription growth [8] - Owlet is the first and only FDA-cleared over-the-counter infant monitoring device, which enhances its competitive positioning and brand trust [9] - Subscription growth is significant, with over 85,000 paying subscribers and a large installed base of more than 650,000 active devices [10] Future Initiatives - Owlet plans to pilot generative AI features in 2026 to enhance user engagement and retention [11] - Regulatory approval in India is expected to open new growth avenues starting early 2026 [12] Challenges - Tariff pressures and elevated import costs are anticipated to impact margins, alongside a cautious consumer spending environment [13] - Despite the shift towards higher-margin software and services, ongoing cost pressures may lead to a year-over-year decline in profitability [13] Stock Performance - Owlet's shares have increased by 53.2% over the past six months, outperforming several industry peers [14] - The stock currently trades at a forward price-to-sales (P/S) ratio of 1.5, significantly lower than the industry average of 8.31 [16] Investment Considerations - Owlet's ongoing transformation towards a data-enabled platform and regulatory strengths present a long-term investment opportunity, despite near-term earnings pressures [19][20]